Abstract
Nerve tissue regeneration is a significant problem. After neural diseases and damage such as spinal cord injury (SCI), the accumulation of chondroitin sulfate proteoglycans (CSPG) comprising axonal inhibitory glycosaminoglycan chains in the microenvironment is a major barrier that obstructs nerve repair. Interfering with the production of glycosaminoglycans, especially the critical inhibitory chains, could be a potential therapeutic strategy for SCI, which is, however, poorly defined. This study identifies Chst15, the chondroitin sulfotransferase controlling the generation of axonal inhibitory chondroitin sulfate-E, as a therapeutic target of SCI. Using a recently reported small molecular Chst15 inhibitor, this study investigates the effects of Chst15 inhibition on astrocyte behaviors and the associated consequences of in vivo disruption of the inhibitory microenvironment. Deposition of CSPGs in the extracellular matrix and migration of astrocytes are both significantly impaired by Chst15 inhibition. Administration of the inhibitor in transected spinal cord tissues of rats effectively promotes motor functional restoration and nerve tissue regeneration by a mechanism related to the attenuation of inhibitory CSPGs, glial scar formation and inflammatory responses. This study highlights the role of Chst15 in the CSPG-mediated inhibition of neural recovery after SCI and proposes an effective neuroregenerative therapeutic strategy that uses Chst15 as a potential target.
Similar content being viewed by others
Data Availability
Datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636–640
Brown JM, Xia J, Zhuang B, Cho KS, Rogers CJ, Gama CI, Rawat M, Tully SE, Uetani N, Mason DE et al (2012) A sulfated carbohydrate epitope inhibits axon regeneration after injury. Proc Natl Acad Sci USA 109:4768–4773
Chakrabarty P, Li A, Ladd TB, Strickland MR, Koller EJ, Burgess JD, Funk CC, Cruz PE, Allen M, Yaroshenko M et al (2018) TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease. J Exp Med 215:2247–2264
Cheung ST, Miller MS, Pacoma R, Roland J, Liu J, Schumacher AM, Hsieh-Wilson LC (2017) Discovery of a small-molecule modulator of glycosaminoglycan sulfation. ACS Chem Biol 12:3126–3133
Davies SJ, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J (1997) Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390:680–683
de Groat WC, Kawatani M, Hisamitsu T, Cheng CL, Ma CP, Thor K, Steers W, Roppolo JR (1990) Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 30(Suppl):S71-77
DiSabato DJ, Quan N, Godbout JP (2016) Neuroinflammation: the devil is in the details. J Neurochem 139(Suppl 2):136–153
Dyck S, Kataria H, Alizadeh A, Santhosh KT, Lang B, Silver J, Karimi-Abdolrezaee S (2018) Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPsigma receptors promotes a beneficial inflammatory response following spinal cord injury. J Neuroinflamm 15:90
Fawcett JW, Oohashi T, Pizzorusso T (2019) The roles of perineuronal nets and the perinodal extracellular matrix in neuronal function. Nat Rev Neurosci 20:451–465
Feliu A, Moreno-Martet M, Mecha M, Carrillo-Salinas FJ, de Lago E, Fernandez-Ruiz J, Guaza C (2015) A Sativex((R)) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. Br J Pharmacol 172:3579–3595
Feliu A, Mestre L, Carrillo-Salinas FJ, Yong VW, Mecha M, Guaza C (2020) 2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions. Glia 68:1255–1273
Ghorbani S, Yong VW (2021) The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis. Brain 144:1958–1973
Hendrix S, Sanchez S, Ventriglia E, Lemmens S (2020) HDAC8 inhibition reduces lesional Iba-1+ cell infiltration after spinal cord injury without effects on functional recovery. Int J Mol Sci 21:4539
Keough MB, Rogers JA, Zhang P, Jensen SK, Stephenson EL, Chen T, Hurlbert MG, Lau LW, Rawji KS, Plemel JR et al (2016) An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination. Nat Commun 7:11312
Li LM, Han M, Jiang XC, Yin XZ, Chen F, Zhang TY, Ren H, Zhang JW, Hou TJ, Chen Z et al (2017) Peptide-tethered hydrogel scaffold promotes recovery from spinal cord transection via synergism with mesenchymal stem cells. ACS Appl Mater Interfaces 9:3330–3342
Li L, Xiao B, Mu J, Zhang Y, Zhang C, Cao H, Chen R, Patra HK, Yang B, Feng S et al (2019) A MnO2 nanoparticle-dotted hydrogel promotes spinal cord repair via regulating reactive oxygen species microenvironment and synergizing with mesenchymal stem cells. ACS Nano 13:14283
Li L, Zhang Y, Mu J, Chen J, Zhang C, Cao H, Gao J (2020) Transplantation of human mesenchymal stem-cell-derived exosomes immobilized in an adhesive hydrogel for effective treatment of spinal cord injury. Nano Lett 20:4298–4305
Luo F, Tran AP, Xin L, Sanapala C, Lang BT, Silver J, Yang Y (2018) Modulation of proteoglycan receptor PTPsigma enhances MMP-2 activity to promote recovery from multiple sclerosis. Nat Commun 9:4126
Maatouk L, Yi C, Carrillo-de Sauvage MA, Compagnion AC, Hunot S, Ezan P, Hirsch EC, Koulakoff A, Pfrieger FW, Tronche F et al (2019) Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity. Cell Death Differ 26:580–596
Mietto BS, Mostacada K, Martinez AM (2015) Neurotrauma and inflammation: CNS and PNS responses. Mediat Inflamm 2015:251204
Mu J-F, Wu J-H, Cao J, Ma T, Li L-M, Feng S-Q, Gao J-Q (2021) Rapid and effective treatment of traumatic spinal cord injury using stem cell derived exosomes. Asian J Pharm Sci 16:806–815
Ohtake S, Ito Y, Fukuta M, Habuchi O (2001) Human N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase cDNA is related to human B cell recombination activating gene-associated gene. J Biol Chem 276:43894–43900
Pantazopoulos H, Markota M, Jaquet F, Ghosh D, Wallin A, Santos A, Caterson B, Berretta S (2015) Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala. Transl Psychiatry 5:e496
Pekny M, Nilsson M (2005) Astrocyte activation and reactive gliosis. Glia 50:427–434
Qi LF, Liu S, Liu YC, Li P, Xu X (2021) Ganoderic acid a promotes amyloid-beta clearance (in vitro) and ameliorates cognitive deficiency in alzheimer’s disease (mouse model) through autophagy induced by activating axl. Int J Mol Sci 22:5559
Romo PGB, Smith CP, Cox A, Averbeck MA, Dowling C, Beckford C, Manohar P, Duran S, Cameron AP (2018) Non-surgical urologic management of neurogenic bladder after spinal cord injury. World J Urol 36:1555–1568
Rubiano AM, Carney N, Chesnut R, Puyana JC (2015) Global neurotrauma research challenges and opportunities. Nature 527:S193-197
Stephenson EL, Mishra MK, Moussienko D, Laflamme N, Rivest S, Ling CC, Yong VW (2018) Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis. Brain 141:1094–1110
Stutchbury B, Atherton P, Tsang R, Wang DY, Ballestrem C (2017) Distinct focal adhesion protein modules control different aspects of mechanotransduction. J Cell Sci 130:1612–1624
Tran AP, Warren PM, Silver J (2018) The biology of regeneration failure and success after spinal cord injury. Physiol Rev 98:881–917
Warford JR, Lamport AC, Clements DR, Malone A, Kennedy BE, Kim Y, Gujar SA, Hoskin DW, Easton AS (2018) Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis. Acta Neuropathol Commun 6:4
Yang J, Yin M, Hou Y, Li H, Guo Y, Yu H, Zhang K, Zhang C, Jia L, Zhang F, Li X, Bian H, Li Z (2022) Role of ammonia for brain abnormal protein glycosylation during the development of hepatitis B virus-related liver diseases. Cell Biosci 12:16.
Acknowledgements
The authors thank the Ocean University of China and the Pilot National Laboratory for Marine Science and Technology for the supports. This work was financially supported by the National Natural Science Foundation of China (22107095, 81803451), Natural Science Fund for Excellent Young Scholars of Shandong Province (ZR2021YQ53), and funded by Pilot National Laboratory for Marine Science and Technology (Qingdao) (JCZX202006).
Funding
This work was financially supported by the National Natural Science Foundation of China (22107095, 81803451), Natural Science Fund for Excellent Young Scholars of Shandong Province (ZR2021YQ53), and funded by Pilot National Laboratory for Marine Science and Technology (Qingdao) (JCZX202006).
Author information
Authors and Affiliations
Contributions
The experiment conduction and the manuscript writing were finished through the contributions of all authors. The study conception and design were mainly from CQ and LL. Drug synthesis and characterization were completed by JB. LL, HZ, and JB performed the cellular and in vivo experiment, data collection, and data analysis. SM and ZL contributed to the manuscript editing, and the manuscript writing was accomplished mainly by LL under the participation of all authors. All the authors have approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors have no relevant financial or non-financial interests to disclose.
Ethical Approval
All animal experiments and procedures were conducted under the approval of the Institutional Animal Care and Use Committee at Ocean University of China.
Consent to Participate
Not applicable.
Consent for Publication
The manuscript contains no individual person’s data in any form.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file2 (MP4 31572 kb)
Supplementary file3 (MP4 14541 kb)
Supplementary file4 (MP4 21993 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, L., Zheng, H., Ma, X. et al. Inhibition of Astrocytic Carbohydrate Sulfotransferase 15 Promotes Nerve Repair After Spinal Cord Injury via Mitigation of CSPG Mediated Axonal Inhibition. Cell Mol Neurobiol 43, 2925–2937 (2023). https://doi.org/10.1007/s10571-023-01333-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-023-01333-9